302 related articles for article (PubMed ID: 15547419)
1. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate.
Choe WT; Chinosornvatana N; Chang KW
Otol Neurotol; 2004 Nov; 25(6):910-5. PubMed ID: 15547419
[TBL] [Abstract][Full Text] [Related]
2. Transtympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model.
Munguia R; Sahmkow SI; Funnell WR; Daniel SJ
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):134-40. PubMed ID: 20620632
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
[TBL] [Abstract][Full Text] [Related]
4. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
5. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy.
Riga MG; Chelis L; Kakolyris S; Papadopoulos S; Stathakidou S; Chamalidou E; Xenidis N; Amarantidis K; Dimopoulos P; Danielides V
Am J Clin Oncol; 2013 Feb; 36(1):1-6. PubMed ID: 22134515
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
7. [Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy].
Hyppolito MA; de Oliveira AA; Lessa RM; Rossato M
Braz J Otorhinolaryngol; 2005; 71(3):268-73. PubMed ID: 16446928
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model.
Yüksel Aslıer NG; Tağaç AA; Durankaya SM; Çalışır M; Ersoy N; Kırkım G; Yurdakoç K; Bağrıyanık HA; Yılmaz O; Sütay S; Güneri EA
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous lactated Ringer's solution infusion on the circulating lactate concentration: Part 3. Results of a prospective, randomized, double-blind, placebo-controlled trial.
Didwania A; Miller J; Kassel D; Jackson EV; Chernow B
Crit Care Med; 1997 Nov; 25(11):1851-4. PubMed ID: 9366769
[TBL] [Abstract][Full Text] [Related]
10. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
Sarafraz Z; Ahmadi A; Daneshi A
Int Tinnitus J; 2018 Jun; 22(1):40-45. PubMed ID: 29993216
[TBL] [Abstract][Full Text] [Related]
11. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the protective effect of α-lipoic acid on cisplatin ototoxicity using distortion-product otoacoustic emission measurements: an experimental animal study.
Ozkul Y; Songu M; Basoglu MS; Ozturkcan S; Katilmis H
J Craniofac Surg; 2014 Jul; 25(4):1515-8. PubMed ID: 24905944
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
14. Effect of transtympanic betamethasone delivery to the inner ear.
Özel HE; Özdoğan F; Gülşen Gürgen S; Esen E; Selçuk A; Genç S
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3053-61. PubMed ID: 26831119
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of melatonin against gentamicin ototoxicity.
Ye LF; Tao ZZ; Hua QQ; Xiao BK; Zhou XH; Li J; Yuan YL
J Laryngol Otol; 2009 Jun; 123(6):598-602. PubMed ID: 18957160
[TBL] [Abstract][Full Text] [Related]
16. Effect of Transtympanic Injection of Melatonin on Cisplatin-Induced Ototoxicity.
Demir MG; Altıntoprak N; Aydın S; Kösemihal E; Başak K
J Int Adv Otol; 2015 Dec; 11(3):202-6. PubMed ID: 26915150
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of eugenol against cisplatin-induced ototoxicity.
Sakat MS; Kilic K; Akdemir FNE; Yildirim S; Eser G; Kiziltunc A
Braz J Otorhinolaryngol; 2019; 85(6):766-773. PubMed ID: 30126770
[TBL] [Abstract][Full Text] [Related]
19. The effects of diaspirin cross-linked hemoglobin on hemodynamics, metabolic acidosis, and survival in burned rats.
Soltero RG; Hansbrough JF
J Trauma; 1999 Feb; 46(2):286-91. PubMed ID: 10029035
[TBL] [Abstract][Full Text] [Related]
20. Normal Saline Solution and Lactated Ringer's Solution Have a Similar Effect on Quality of Recovery: A Randomized Controlled Trial.
Friederich A; Martin N; Swanson MB; Faine BA; Mohr NM
Ann Emerg Med; 2019 Feb; 73(2):160-169. PubMed ID: 30146446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
